Zhejiang Huahai Pharmaceutical Secures Orphan Drug Designation for HB0034
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) has announced that it has received orphan...
Merck KGaA Partners with Porton Pharma for Next-Gen ADC Platform Development
German pharmaceutical giant Merck KGaA (ETR: MRK) has entered into a strategic partnership with China-based...
Lepu Medical Gains NMPA Approval for Semi-Automatic External Defibrillator
China-based cardiovascular disease solutions provider Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003) has announced...
BeiGene’s Tislelizumab Shows Promising Results in ESMO Presentations for GC/GEJC and NSCLC
China-based biotech BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235) has announced two late-breaking presentations...
Bayer Partners with HALO Precision Diagnostics to Develop Gadoquatrane for MRI Applications
Germany-based Bayer (ETR: BAYN) has announced a strategic partnership with US radiology expert HALO Precision...
Hong Kong WinHealth Pharma Enters Strategic Partnership with Nippon Shinyaku for Irsogladine
Hong Kong-based WinHealth Pharma Group Ltd has announced a strategic partnership with Nippon Shinyaku Co...
Gilead Partners with Assembly Biosciences in $84.8 Million Collaboration for Antiviral Therapies
Gilead Sciences (NASDAQ: GILD) has announced a significant 12-year collaboration with antiviral specialist Assembly Biosciences...
J&J Reports Strong Q3 2023 Sales Growth Amid Diverse Business Performance
Johnson & Johnson (J&J; NYSE: JNJ) has released its Q3 2023 report, revealing impressive global...
Huadong Medicine Secures Global Licensing Agreement for ATGC-110 Botulinum Toxin A Injection
China-based Huadong Medicine Co., Ltd. (SHE: 000963) has announced a strategic licensing agreement with South...
Apeloa Pharmaceutical Enters Ten-Year Partnership with Wuhan Hesheng Technology
China-based contract development and manufacturing organization (CDMO) Apeloa Pharmaceutical Co., Ltd. (SHE: 000739) has announced...
BeiGene Submits Supplementary BLA for Tislelizumab in Small Cell Lung Cancer
BeiGene (NASDAQ: BGNE) has announced that its supplementary Biologic License Application (sBLA) for the programmed...
Mabwell to Present Promising Clinical Data at 2023 ESMO Congress
China-based Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062) has announced that it will present the...
Sirius Therapeutics Secures USD 60 Million in Series B Financing for siRNA Therapy Development
Sirius Therapeutics, a Shanghai-based developer of siRNA therapies, has successfully raised USD 60 million in...
SciClone Pharmaceuticals Partners with Shanghai Pharmaceutical and Menarini Group
China’s SciClone Pharmaceuticals Inc. (HKG: 6600) has entered into a collaborative agreement with Shanghai Pharmaceuticals...
Baidu Launches Interactive AI Medication Instructions Service at Baidu World 2023
Robin Li, CEO of China-based internet services giant Baidu, unveiled an innovative interactive AI medication...
Novo Nordisk Strikes $1.3 Billion Deal for KBP Biosciences’ Ocedurenone
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) announced a significant deal this week, valued at...
Ascentage Pharma and AstraZeneca Expand Collaboration on CLL/SLL Treatment
China’s Ascentage Pharma (HKG: 6855) and UK-based pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) have entered...
Asieris Pharma Launches Generic Votrient for Renal Cell Carcinoma in China
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd, trading as Asieris Pharma (SHA: 688176),...
BeiGene’s Brukinsa Receives Positive CHMP Opinion for Follicular Lymphoma Treatment
China-based biotechnology leader BeiGene (NASDAQ: BGNE; HKG: 6160; SHA: 688235) has announced the receipt of...
EpimAb Biotherapeutics Licenses Bispecific Antibody Platform to Almirall
Shanghai-based EpimAb Biotherapeutics has entered into a strategic license agreement with Spanish pharmaceutical company Almirall...